Jane Lebkowski Net Worth & Insider Trades

Jane Lebkowski - Chief Scientific Officer, Asterias Biotherapeutics, Inc

As of June 7, 2017

What is Jane Lebkowski's Net Worth?

The current estimated net worth of Asterias Biotherapeutics, Inc's Chief Scientific Officer, Jane Lebkowski, is estimated to be about $674.1K . Jane Lebkowski owns about 476 units of Asterias Biotherapeutics, Inc common stock. In the last 2 years at Asterias Biotherapeutics, Inc, Jane Lebkowski has sold an estimated value of $65K worth.

What is Jane Lebkowski's Past Insider Trading?

Jane Lebkowski's largest sale order was 4,912 units , worth over $29.47K on September 16, 2015. In total, Jane Lebkowski has made about 9 transactions over 2 years of their time at Asterias Biotherapeutics, Inc. Jane Lebkowski usually trades in March, with the busiest year in 2016, 2017 and 2015.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Jane Lebkowski

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Jane Lebkowski's' Mailing Address?

  • Mailing address is 230 Constitution Drive Menlo Park CA 94025 CA

What are Asterias Biotherapeutics, Inc's Past Insider Trades?

Asterias Biotherapeutics, Inc's most recent insider trade came on August 29, 2018 by Michael H Mulroy who bought 3,141 units worth $5K . In the last 3 years, insiders at Asterias Biotherapeutics, Inc have sold an estimated value of $777.1K and bought an estimated value of $6.11M worth of shares. Insider trading is most common in March, with the busiest year in 2016. The most active traders at the company are Edward Wirth, Chief Medical Officer,  Katharine E Spink, EVP & COO,  and Michael H Mulroy, President and CEO .

Asterias Biotherapeutics, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...